<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>tinzaparin</title><link>http://www.unboundmedicine.com/medline/ebm/research/tinzaparin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888521/full_citation/Structural_features_of_low_molecular_weight_heparins_affecting_their_affinity_to_antithrombin_</link><description>Bisio A, Vecchietti D, Citterio L, et al. <br/><span class="title">Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. [Journal Article]</span><br/><span class="source" title="Thrombosis and haemostasis">Thromb Haemost 2009 Nov; 102(5):865-73.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888521/abstract/Structural_features_of_low_molecular_weight_heparins_affecting_their_affinity_to_antithrombin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19888521/full_citation/Structural_features_of_low_molecular_weight_heparins_affecting_their_affinity_to_antithrombin_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19888521/Structural_features_of_low_molecular_weight_heparins_affecting_their_affinity_to_antithrombin_">Find Related Articles</a> </description></item><item><title>Binding between heparin and the integrin VLA-4.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888514/full_citation/Binding_between_heparin_and_the_integrin_VLA_4_</link><description>Schlesinger M, Simonis D, Schmitz P, et al. <br/><span class="title">Binding between heparin and the integrin VLA-4. [Journal Article]</span><br/><span class="source" title="Thrombosis and haemostasis">Thromb Haemost 2009 Nov; 102(5):816-22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888514/abstract/Binding_between_heparin_and_the_integrin_VLA_4_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19888514/full_citation/Binding_between_heparin_and_the_integrin_VLA_4_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19888514/Binding_between_heparin_and_the_integrin_VLA_4_">Find Related Articles</a> </description></item><item><title>Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19882795/full_citation/Tinzaparin:_excess_mortality_in_elderly_patients_with_renal_failure__Unfractionated_heparin_is_best_in_this_setting_</link><description><span class="title">Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting. [Journal Article]</span><br/><span class="source" title="">Prescrire Int 2009 Oct; 18(103):216.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19882795/full_citation/Tinzaparin:_excess_mortality_in_elderly_patients_with_renal_failure__Unfractionated_heparin_is_best_in_this_setting_">Full Citation</a></description></item><item><title>[Low-molecular-weight heparin-induced bullous haemorrhagic dermatosis associated with cell-mediated hypersensitivity.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19801254/full_citation/[Low_molecular_weight_heparin_induced_bullous_haemorrhagic_dermatosis_associated_with_cell_mediated_hypersensitivity_]</link><description>Thuillier D, Chaby G, Dadban A, et al. <br/><span class="title">[Low-molecular-weight heparin-induced bullous haemorrhagic dermatosis associated with cell-mediated hypersensitivity.] [English Abstract, Journal Article]</span><br/><span class="source" title="Annales de dermatologie et de vénéréologie">Ann Dermatol Venereol 2009 Oct; 136(10):705-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19801254/abstract/[Low_molecular_weight_heparin_induced_bullous_haemorrhagic_dermatosis_associated_with_cell_mediated_hypersensitivity_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19801254/full_citation/[Low_molecular_weight_heparin_induced_bullous_haemorrhagic_dermatosis_associated_with_cell_mediated_hypersensitivity_]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19801254/[Low_molecular_weight_heparin_induced_bullous_haemorrhagic_dermatosis_associated_with_cell_mediated_hypersensitivity_]">Find Related Articles</a> </description></item><item><title>Low-molecular-weight heparin in patients with renal insufficiency.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19685350/full_citation/Low_molecular_weight_heparin_in_patients_with_renal_insufficiency_</link><description>Schmid P, Fischer AG, Wuillemin WA <br/><span class="title">Low-molecular-weight heparin in patients with renal insufficiency. [Journal Article]</span><br/><span class="source" title="Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology">Swiss Med Wkly 2009 Aug 8; 139(31-32):438-52.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19685350/abstract/Low_molecular_weight_heparin_in_patients_with_renal_insufficiency_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19685350/full_citation/Low_molecular_weight_heparin_in_patients_with_renal_insufficiency_">Full Citation</a></description></item><item><title>Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19674314/full_citation/Review_article:_Low_molecular_weight_heparin_as_an_alternative_anticoagulant_to_unfractionated_heparin_for_routine_outpatient_haemodialysis_treatments_</link><description>Davenport A <br/><span class="title">Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. [Journal Article]</span><br/><span class="source" title="Nephrology (Carlton, Vic.)">Nephrology (Carlton) 2009 Aug; 14(5):455-61.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19674314/abstract/Review_article:_Low_molecular_weight_heparin_as_an_alternative_anticoagulant_to_unfractionated_heparin_for_routine_outpatient_haemodialysis_treatments_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19674314/full_citation/Review_article:_Low_molecular_weight_heparin_as_an_alternative_anticoagulant_to_unfractionated_heparin_for_routine_outpatient_haemodialysis_treatments_">Full Citation</a></description></item><item><title>Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19652876/full_citation/Anti_cancer_properties_of_low_molecular_weight_heparin:_Preclinical_evidence_</link><description>Mousa SA, Petersen LJ <br/><span class="title">Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence. [JOURNAL ARTICLE]</span><br/><span class="source" title="Thrombosis and haemostasis">Thromb Haemost 2009; 102(2):258-267.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19652876/abstract/Anti_cancer_properties_of_low_molecular_weight_heparin:_Preclinical_evidence_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19652876/full_citation/Anti_cancer_properties_of_low_molecular_weight_heparin:_Preclinical_evidence_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19652876/Anti_cancer_properties_of_low_molecular_weight_heparin:_Preclinical_evidence_">Find Related Articles</a> </description></item><item><title>Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19635277/full_citation/Home_therapy_of_venous_thrombosis_with_long_term_LMWH_versus_usual_care:_patient_satisfaction_and_post_thrombotic_syndrome_</link><description>Hull RD, Pineo GF, Brant R, et al. <br/><span class="title">Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome. [Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="The American journal of medicine">Am J Med 2009 Aug; 122(8):762-769.e3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19635277/abstract/Home_therapy_of_venous_thrombosis_with_long_term_LMWH_versus_usual_care:_patient_satisfaction_and_post_thrombotic_syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19635277/full_citation/Home_therapy_of_venous_thrombosis_with_long_term_LMWH_versus_usual_care:_patient_satisfaction_and_post_thrombotic_syndrome_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(09)00330-1">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19635277/Home_therapy_of_venous_thrombosis_with_long_term_LMWH_versus_usual_care:_patient_satisfaction_and_post_thrombotic_syndrome_">Find Related Articles</a> </description></item><item><title>Long term administration of LMWH - pharmacodynamic parameters under therapeutic or prophylactic regimen of enoxaparin or tinzaparin in neurological rehabilitation patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19625075/full_citation/Long_term_administration_of_LMWH___pharmacodynamic_parameters_under_therapeutic_or_prophylactic_regimen_of_enoxaparin_or_tinzaparin_in_neurological_rehabilitation_patients_</link><description>Kuczka K, Baum K, Picard-Willems B, et al. <br/><span class="title">Long term administration of LMWH - pharmacodynamic parameters under therapeutic or prophylactic regimen of enoxaparin or tinzaparin in neurological rehabilitation patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Thrombosis research">Thromb Res 2009 Jul 20.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19625075/abstract/Long_term_administration_of_LMWH___pharmacodynamic_parameters_under_therapeutic_or_prophylactic_regimen_of_enoxaparin_or_tinzaparin_in_neurological_rehabilitation_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19625075/full_citation/Long_term_administration_of_LMWH___pharmacodynamic_parameters_under_therapeutic_or_prophylactic_regimen_of_enoxaparin_or_tinzaparin_in_neurological_rehabilitation_patients_">Full Citation</a></description></item><item><title>Treatment of Pulmonary Embolism in an Extremely Obese Patient.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19506978/full_citation/Treatment_of_Pulmonary_Embolism_in_an_Extremely_Obese_Patient_</link><description>Diepstraten J, van Kralingen S, Snijder RJ, et al. <br/><span class="title">Treatment of Pulmonary Embolism in an Extremely Obese Patient. [JOURNAL ARTICLE]</span><br/><span class="source" title="Obesity surgery">Obes Surg 2009 Jun 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19506978/abstract/Treatment_of_Pulmonary_Embolism_in_an_Extremely_Obese_Patient_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19506978/full_citation/Treatment_of_Pulmonary_Embolism_in_an_Extremely_Obese_Patient_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19506978/Treatment_of_Pulmonary_Embolism_in_an_Extremely_Obese_Patient_">Find Related Articles</a> </description></item></channel></rss>